Lobbyist Public Search

Records prior to registration year 2005 are not available online. Contact the Lobbyist Division here for assistance.	Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
	Your comments are welcome: submit feedback

Disclosure reporting details

Back to search detail summary

Lobbyist disclosure reporting period: 07/01/2019 - 12/31/2019

Lobbyist name	Leslie Wood
Business name	Pharmaceutical Research and Manufacturers of America, Inc.
Address	950 F Street, NW Suite 300
City, state, zip code	Washington, DC 20004
Country	US
Agent type	Both
Phone	202-835-3451

Operating Expenses

No operating expenses were filed for this disclosure reporting period.

Activities, Bill Numbers and Titles

Client: Pharmaceutical Research and Manufacturers of America, Inc.

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
Executive	Center for Health Information and Analysis (CHIA)	Commented on the CHIA Cost Trends Report Performance of the Massachusetts Health Care System	Neutral	$1,911.70	N/A
House Bill	4246	An Act making appropriations for the fiscal year 2019 to provide for supplementing certain existing appropriations and for certain other activities and projects	Support	$152.08	N/A
Senate Bill	1301	An Act to prevent undue influence on prescriber behavior	Oppose	$260.60	N/A
House Bill	4134	An Act to improve health care by investing in VALUE	Oppose	$2,281.20	N/A
House Bill	1972	An Act to permit the wholesale importation of prescription drugs into the Commonwealth	Oppose	$260.60	N/A
House Bill	1	making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements	Oppose	$651.50	N/A
Executive	Massachusetts Health Policy Commission (HPC)	Discussed proposed regulation 958 CMR 12.00: DRUG PRICING REVIEW	Neutral	$3,802.00	N/A
Executive	Executive Office of Health and Human Services (EOHHS)	Discussed proposed regulation 101 CMR 801.00: DRUG MANUFACTURER NEGOTIATIONS AND ACCOUNTABILITY	Neutral	$2,281.20	N/A
Senate Bill	1304	An Act to restore integrity in the marketing of pharmaceutical products and medical devices	Oppose	$260.60	N/A
Senate Bill	2409	An Act relative to pharmaceutical access, costs and transparency	Oppose	$3,041.60	N/A
			Total amount	$14,903.08

Meals, Travel, and Entertainment Expenses

No meals, travel, or entertainment expenses were filed for this disclosure reporting period.

Additional Expenses

No additional expenses were filed for this disclosure reporting period.

Campaign Contributions

No campaign contributions were filed for this disclosure reporting period.

Close this page

Connect with Us